Shaping the new Takeda: Frank Morich
This article was originally published in Scrip
Executive Summary
Eleanor Malone talked with Takeda’s Frank Morich twice over a six month period during which the Japanese pharma major has been digesting its Nycomed buy. Highlighted throughout their conversations was the importance of communication and a realistic growth strategy to help Takeda reach its full potential.